@bellmatic (reply broken) - I think one can start valuation with using RC110 phase 2 results in AML. Then add the AML ODD & RPD.
Now add everything else with marginal likelihood of success then you should definitely end up more than current SP. if everything is proven in the clinic (like CPACS, FTO), it would be naive to assume we could still buy shares at current SP. Investors buying with uncertainty can buy cheaper than with certainty. You all know this.
AIMO. DYOR.
Ann: Race In-person Investor Briefing Invitation Perth, page-41
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
